These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Effects of probiotics on the intestinal microecological abnormalities and colorectal cancer of mice induced by high-fat diet]. He JD; Kong C; Gao RY; Yin F; Zhang Y; Qin HL Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):77-85. PubMed ID: 32594730 [No Abstract] [Full Text] [Related]
43. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade. Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166 [TBL] [Abstract][Full Text] [Related]
44. [Role of gut microbiota in carcinogenesis and treatment for colorectal cancer]. Zhang W; Jiang KW Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):516-520. PubMed ID: 32842435 [TBL] [Abstract][Full Text] [Related]
45. The Protective Role of Probiotics against Colorectal Cancer. Ding S; Hu C; Fang J; Liu G Oxid Med Cell Longev; 2020; 2020():8884583. PubMed ID: 33488940 [TBL] [Abstract][Full Text] [Related]
46. Effect of gut microbiota in the colorectal cancer and potential target therapy. Li J; Zhu Y; Yang L; Wang Z Discov Oncol; 2022 Jun; 13(1):51. PubMed ID: 35749000 [TBL] [Abstract][Full Text] [Related]
47. [The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer]. Wasilewska E; Złotkowska D; Pijagin ME Postepy Hig Med Dosw (Online); 2013 Aug; 67():837-47. PubMed ID: 24018449 [TBL] [Abstract][Full Text] [Related]
48. Potential Mechanisms of Probiotics Action in the Prevention and Treatment of Colorectal Cancer. Molska M; Reguła J Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615096 [TBL] [Abstract][Full Text] [Related]
49. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism. Wei Z; Cao S; Liu S; Yao Z; Sun T; Li Y; Li J; Zhang D; Zhou Y Oncotarget; 2016 Jul; 7(29):46158-46172. PubMed ID: 27323816 [TBL] [Abstract][Full Text] [Related]
50. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299 [TBL] [Abstract][Full Text] [Related]
51. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717 [TBL] [Abstract][Full Text] [Related]
52. Intestinal microbiota, chronic inflammation, and colorectal cancer. Park CH; Eun CS; Han DS Intest Res; 2018 Jul; 16(3):338-345. PubMed ID: 30090032 [TBL] [Abstract][Full Text] [Related]
53. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Bultman SJ Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27138454 [TBL] [Abstract][Full Text] [Related]
54. Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. Zhao H; He M; Zhang M; Sun Q; Zeng S; Chen L; Yang H; Liu M; Ren S; Meng X; Xu H Am J Chin Med; 2021; 49(4):805-828. PubMed ID: 33827382 [TBL] [Abstract][Full Text] [Related]
55. Intestinal bacteria and colorectal cancer: etiology and treatment. Dougherty MW; Jobin C Gut Microbes; 2023; 15(1):2185028. PubMed ID: 36927206 [TBL] [Abstract][Full Text] [Related]
56. Role of the intestinal microbiome in colorectal cancer surgery outcomes. Lauka L; Reitano E; Carra MC; Gaiani F; Gavriilidis P; Brunetti F; de'Angelis GL; Sobhani I; de'Angelis N World J Surg Oncol; 2019 Dec; 17(1):204. PubMed ID: 31791356 [TBL] [Abstract][Full Text] [Related]
57. Single probiotic supplement suppresses colitis-associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis. Rong J; Liu S; Hu C; Liu C J Gastroenterol Hepatol; 2019 Jul; 34(7):1182-1192. PubMed ID: 30357910 [TBL] [Abstract][Full Text] [Related]
58. Gut microbiota imbalance and colorectal cancer. Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603 [TBL] [Abstract][Full Text] [Related]
59. Phages Enter the Fight against Colorectal Cancer. Kannen V; Parry L; Martin FL Trends Cancer; 2019 Oct; 5(10):577-579. PubMed ID: 31706504 [TBL] [Abstract][Full Text] [Related]
60. Tumour-associated and non-tumour-associated microbiota: Addendum. Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]